Ocugen (OCGN) Non-Current Debt (2014 - 2026)
Ocugen (OCGN) posted Non-Current Debt of $24.2 million for Q1 2026, down 12.17% on a QoQ basis from $27.5 million in Q4 2025, and down 12.58% year-over-year from $27.7 million in Q1 2025.
Ocugen (OCGN) Non-Current Debt (2014 - 2026) Analysis & Trends
Ocugen's Non-Current Debt history runs 13 years deep, the most recent figure standing at $24.2 million for Q1 2026.
- Quarterly Non-Current Debt fell 12.58% year-over-year to $24.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $24.2 million (down 12.58% YoY) and the FY2025 annual result came in at $27.5 million, up 0.72% from the prior year.
- Non-Current Debt was $24.2 million for Q1 2026 at Ocugen, down from $27.5 million in the prior quarter.
- Across five years, Non-Current Debt topped out at $28.4 million in Q3 2025 and bottomed at $1.1 million in Q1 2023.
- A 5-year average of $10.7 million and a median of $2.3 million in 2022 frame the typical range for Non-Current Debt.
- Annual changes were most pronounced in 2023 — Non-Current Debt tumbled 38.88% — and 2025, when it jumped 1707.77%.
- Ocugen's Non-Current Debt stood at $2.3 million in 2022, then advanced by 22.32% to $2.8 million in 2023, then jumped by 876.61% to $27.3 million in 2024, then gained by 0.72% to $27.5 million in 2025, then dropped by 12.17% to $24.2 million in 2026.
- Business Quant data shows OCGN's Non-Current Debt at $24.2 million in Q1 2026, $27.5 million in Q4 2025, and $28.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 105.94 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 842.92 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.99 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Ocugen | 63.79 Mn | 63.79 Mn | - | 24.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.19 Mn |
| Dec 31, 2025 | 27.54 Mn |
| Sep 30, 2025 | 28.40 Mn |
| Jun 30, 2025 | 28.03 Mn |
| Mar 31, 2025 | 27.67 Mn |
| Dec 31, 2024 | 27.35 Mn |
| Sep 30, 2024 | 1.57 Mn |
| Jun 30, 2024 | 1.55 Mn |
| Mar 31, 2024 | 1.53 Mn |
| Dec 31, 2023 | 2.80 Mn |
| Sep 30, 2023 | 1.50 Mn |
| Jun 30, 2023 | 1.47 Mn |
| Mar 31, 2023 | 1.06 Mn |
| Dec 31, 2022 | 2.29 Mn |
| Sep 30, 2022 | 2.27 Mn |
| Jun 30, 2022 | 1.75 Mn |
| Mar 31, 2022 | 1.73 Mn |
| Dec 31, 2021 | 1.71 Mn |
| Sep 30, 2021 | 1.69 Mn |
| Jun 30, 2021 | 1.67 Mn |